ENvue Medical (FEED) Cash from Investing Activities Growth (3y) (2018 - 2026)
ENvue Medical (FEED) Cash from Investing Activities Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.93 Bn | 193.33 Bn | 7.27 Bn | 17.83% |
| 2 | Stryker | 128.56 Bn | 125.08 Bn | 4.50 Bn | -6.23% |
| 3 | Medtronic | 119.26 Bn | 110.04 Bn | 6.41 Bn | -24.52% |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn | -32.54% |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn | -68.12% |
| 6 | Dexcom | 34.55 Bn | 32.61 Bn | 830.00 Mn | 37.39% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | -11.04% |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn | 19.58% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | -17.67% |
| 10 | ENvue Medical | 2.52 Mn | 1.38 Mn | -266,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -157.13% |
| Dec 31, 2025 | -192.40% |
| Sep 30, 2025 | -141.01% |
| Mar 31, 2024 | 20.63% |
| Sep 30, 2021 | 30.66% |
| Mar 31, 2021 | 0.00% |
| Jun 30, 2018 | -44.22% |